Stock Events

Stock Events

Compass Pathways 

$13.10
342
-$0.19-1.47% 15:02 Today

Statistics

Day High
13.38
Day Low
13.05
52W High
15.4
52W Low
4.82
Volume
204,515
Avg. Volume
3,395,650
Mkt Cap
1.81B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31JulExpected
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.63
-0.5
-0.37
-0.24
Expected EPS
-0.38
Actual EPS
-0.41

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-287.86MNet Income

Analyst Ratings

24.00Average Price Target
The highest estimate is 65.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
91%
Hold
9%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CMPS. It's not an investment recommendation.
Amazon
45
AMZN
Tesla
44
TSLA
NVIDIA
44
NVDA
Microsoft
40
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AtaiBeckley
ATAI
Mkt Cap2.7B
ATAI Life Sciences works on developing psychedelic and non-psychedelic compounds for mental health, a direct competitor in the psychedelic medicine field.
GH Research
GHRS
Mkt Cap1.92B
GH Research is focused on developing 5-MeO-DMT therapies for mental health disorders, competing in the same therapeutic area as Compass Pathways.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness focuses on psychedelic production and therapy, competing with Compass Pathways in the psychedelic mental health treatment market.
State Street My2035 Corporate Bond
MYCO
Mkt Cap0
Mydecine Innovations Group is engaged in the development of psychedelic medicines, competing in the same space as Compass Pathways.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics is exploring the use of psychedelics for the treatment of mental illness and addiction, making it a competitor in the psychedelic therapy market.

About

Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
Show more...
CEO
Kabir Kumar Nath
Employees
156
Country
United Kingdom
ISIN
US20451W1018
WKN
000A2QCDR

Listings

MX
MX
CMPSN.MX
F
DE
5Y6.F
STU
DE
5Y6.STU
MU
DE
5Y6.MU

0 Comments

Share your thoughts

FAQ

What is Compass Pathways stock price today?▼
The current price of CMPS is $13.10 USD — it has decreased by -1.47% in the past 24 hours. Watch Compass Pathways stock price performance more closely on the chart.
What is Compass Pathways stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Compass Pathways stocks are traded under the ticker CMPS.
Is Compass Pathways stock price growing?▼
CMPS stock has fallen by -4.62% compared to the previous week, the month change is a +10.97% rise, over the last year Compass Pathways has showed a +156.76% increase.
What is Compass Pathways market cap?▼
Today Compass Pathways has the market capitalization of 1.81B
What were Compass Pathways earnings last quarter?▼
CMPS earnings for the last quarter are -0.41 USD per share, whereas the estimation was -0.38 USD resulting in a -7.89% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Compass Pathways revenue for the last year?▼
Compass Pathways revenue for the last year amounts to 0 USD.
What is Compass Pathways net income for the last year?▼
CMPS net income for the last year is -287.86M USD.
How many employees does Compass Pathways have?▼
As of September 04, 2026, the company has 156 employees.
In which sector is Compass Pathways located?▼
Compass Pathways operates in the Health & Wellness sector.
When did Compass Pathways complete a stock split?▼
Compass Pathways has not had any recent stock splits.
Where is Compass Pathways headquartered?▼
Compass Pathways is headquartered in CHESIRE, United Kingdom.